APA (7th ed.) Citation

Burgess, D. S., Frei, C. R., Lewis II, J. S., Fiebelkorn, K. R., & Jorgensen, J. H. (2007). The contribution of pharmacokinetic–pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis. Clinical Microbiology & Infection, 13(1), 33. https://doi.org/10.1111/j.1469-0691.2006.01617.x

Chicago Style (17th ed.) Citation

Burgess, D. S., C. R. Frei, J. S. Lewis II, K. R. Fiebelkorn, and J. H. Jorgensen. "The Contribution of Pharmacokinetic–pharmacodynamic Modelling with Monte Carlo Simulation to the Development of Susceptibility Breakpoints for Neisseria Meningitidis." Clinical Microbiology & Infection 13, no. 1 (2007): 33. https://doi.org/10.1111/j.1469-0691.2006.01617.x.

MLA (9th ed.) Citation

Burgess, D. S., et al. "The Contribution of Pharmacokinetic–pharmacodynamic Modelling with Monte Carlo Simulation to the Development of Susceptibility Breakpoints for Neisseria Meningitidis." Clinical Microbiology & Infection, vol. 13, no. 1, 2007, p. 33, https://doi.org/10.1111/j.1469-0691.2006.01617.x.